Gastrointestinal Cancer News

Researchers at University of Washington have developed a smartphone app designed to detect jaundice, a common early symptom of pancreatic cancer.

Patients in the U.K. were more likely to undergo flexible sigmoidoscopy screening if they received a second follow-up reminder that included a brochure that addressed common concerns about the procedure, according to a study published in The Annals of Behavioral Medicine.

A novel blood assay successfully identified tumor-specific DNA and protein biomarkers in a cohort of patients with early-stage pancreatic cancer.

More than 10 years of oral contraceptive use appeared associated with significant reductions in risk for ovarian and endometrial cancers, according to data published in JAMA Oncology.

During a study of Lynch syndrome risks, researchers identified two genes that, when mutated, can double a woman’s risk for developing breast cancer by the age of 60, according to a study published in Genetics in Medicine.

The addition of sorafenib to transarterial chemoembolization improved PFS among patients with unresectable hepatocellular carcinoma, according to results of a randomized phase 2 trial presented at the Gastrointestinal Cancers Symposium.

by Leah Christl, PhD

Exelixis and Ipsen announced results from the phase 3 Celestial trial of cabozantinib for hepatocellular carcinoma that showed significant overall survival benefit in patients previously treated for advanced HCC, according to a press release and data presented at the 2018 ASCO-GI Symposium in San Francisco.

The use of robot-assisted minimally invasive thoraco-laparoscopic esophagectomy led to fewer overall complications, as well as surgery- and pulmonary-related complications, than open transthoracic esophagectomy among patients with resectable esophageal cancer, according to study data presented at the Gastrointestinal Cancers Symposium.

Inflammation-causing diets, or those high in meats, refined grains and high-calorie beverages, appeared associated with a higher risk for developing colorectal cancer, according to results published in JAMA Oncology.